Point72 (Difc) LTD Fibrogen Inc Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Fibrogen Inc stock. As of the latest transaction made, Point72 (Difc) LTD holds 52,254 shares of FGEN stock, worth $17,766. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,254
Previous 6,264
734.2%
Holding current value
$17,766
Previous $14.7 Million
216.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FGEN
# of Institutions
110Shares Held
55.5MCall Options Held
2.14MPut Options Held
1.42M-
Primecap Management CO Pasadena, CA9.91MShares$3.37 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$3.04 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$819,2810.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $31.9M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...